A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Docetaxel|DRUG: Nab-paclitaxel|DRUG: Paclitaxel|DRUG: Pertuzumab|DRUG: Trastuzumab
Sponsor: Hoffmann-La Roche